Bovine hepacivirus (BovHepV) is a recently added member to the growing genus 
| INTRODUCTION
With approximately 71 million people suffering from chronic hepatitis C virus (HCV) infection, HCV still represents a major cause for chronic liver disease including fibrosis, cirrhosis and progression to hepatocellular carcinoma (HCC), in both developing and industrialized countries (Hepatitis C WHO fact sheet; October 2017). In the absence of a vaccine, novel treatment options take on greater significance in the control of infection (Alkhouri, Lawitz, & Poordad, 2017; Wirth & Manns, 2016) . Approximately three to four million people are newly infected each year. However, acute HCV infections are, if at all, mostly accompanied by mild and rather unspecific symptoms and therefore stay often unrecognized (Perz, Armstrong, Farrington, Hutin, & Bell, 2006; Westbrook & Dusheiko, 2014) . The majority of infected individuals do not clear the virus spontaneously and develop chronic infection which is a primary reason for end-stage liver disease and HCC (Westbrook & Dusheiko, 2014) . Although non-human primates can be infected experimentally, humans represent the only natural host species (Boonstra, van der Laan, Vanwolleghem, & Janssen, 2009; Simmonds, 2013) . Nevertheless, HCV related viruses have been detected in a wide range of animals expanding the variability and host range of hepaciviruses within the family Flaviviridae (Hartlage, Cullen, & Kapoor, 2016; Simmonds et al., 2017; Smith et al., 2016) which opens new perspectives regarding animal models for HCV. While Nonprimate hepacivirus (NPHV) of horses represents the closest relative to HCV highlighting its particular importance for studying HCV-related infections in animal models (Pfaender et al., 2015 Ramsay et al., 2015; Scheel et al., 2015) , mouse and rat models are easier to realize and less cost-intensive compared to large animals models (Billerbeck et al., 2017; Trivedi et al., 2017) .
After discovery of BovHepV in cattle from Germany and Ghana Corman et al., 2015) , hepaciviruses have been detected in bovine samples from the US, Brazil, and China demonstrating a wide distribution in cattle populations of different continents (Canal et al., 2017; Deng, Guan, Wang, Hao, & Rasmussen, 2018; Lu et al., 2018; Sadeghi et al., 2017) . Infectious agents of livestock animals may cause significant economic losses and may directly or indirectly have impact on consumers; aside from negatively affecting productivity goals, zoonotic bacteria or viruses can be transferred through multiple ways and can lead to severe diseases in human individuals (Cutler, Fooks, & van der Poel, 2010; Kingsley, 2016) . Further studies on BovHepV are required to investigate its host range, course of infection and importance as a possible pathogen for cattle and will contribute to an improved understanding of the evolution of hepaciviruses. Like HCV, bovine hepaciviruses possess a single-stranded positively orientated RNA genome organized as one large open reading frame of 8,340 nucleotides. Detailed genomic analyses revealed that the resulting polyprotein is presumably co-and post-translationally cleaved by cellular and viral proteases resulting in the mature structural (C, E1, E2) and nonstructural (NS2, NS3, NS4A, NS4B, NS5A, and NS5B) proteins . Previously, large proportions of virus positive animals could be detected in BovHepV positive cattle herds where the virus is able to establish persistent infections . It was assumed that the virus most likely replicates in the liver, but so far it remains unknown if such chronic infections are also accompanied by liver disease.
Immune responses to newly identified hepaciviruses such as NPHV have been studied through application of the luciferase immunoprecipitation system (LIPS) which confirmed widespread NPHV infections in horses (Burbelo et al., 2012; Reichert et al., 2017) . For hepaciviral infections of cattle, corresponding cross-sectional serological analyses targeting the dissemination of BovHepV as well as assessment of humoral immune responses in the context of acute and persistent infections are still pending.
Although BovHepV was initially identified in bovine serum samples, it remains to be determined whether additional animal species are susceptible to infections with BovHepV. In vitro studies have indicated that the bovine hepaciviral NS3/4A protease is able to circumvent human host immune response by cleaving the cellular innate immune adaptor MAVS (mitochondrial antiviral signaling protein). Thus, in case of zoonotic exposure, human MAVS would most presumably not restrain BovHepV propagation and spread (Anggakusuma et al., 2016) .
The aims of our study were to establish extended tools to investigate the dissemination of BovHepV and corresponding antibodies in cattle and to explore the nature of BovHepV infections in detail by studying a virus positive cohort for a period of 1 year. Preliminary examination of the host tropism of this virus further contributed to an enhanced understanding of bovine hepacivirus infections.
| MATERIALS AND METHODS

| Serum samples
Bovine blood samples (n = 282) were obtained from official veterinary laboratories (n = 109, apparently healthy dairy cows) and from animals submitted to the Clinic for Cattle, University of Veterinary Medicine Hannover (n = 173). Animals aged one month to 13 years (median: 52 months, 12 male and 161 female animals) were delivered to the Clinic for Cattle due to various internal medical conditions, surgical, or obstetric disease. Of each animal, serum concentrations of hepatic enzymes were determined upon arrival. In addition, 25 out of 40 animals from a BovHepV positive cattle herd identified in a former study were repeatedly investigated over one year in intervals of two or three months. This dairy herd comprised 200 cows housed in four different stable compartments; in the previous study, ten animals were chosen from each compartment. Sampling was approved by the Lower Saxony's official authorities (LAVES AZ 15A602). Porcine serum samples (n = 100 sows from ten herds and n = 100 fattening pigs from ten herds) were derived from official veterinary laboratories. Equine serum samples (n = 117 from adult apparently healthy horses), analyzed in this study were taken during routine health monitoring, and had previously been analyzed for equine hepaci-and pegiviruses (Postel, Cavalleri, et al., 2016) . Human peripheral blood samples (n = 200) were collected from healthy volunteer blood donors recruited by the Institute of Transfusion Medicine of the University Medical Center Hamburg-Eppendorf. All blood donations were performed in accordance with the latest guidelines of the German Federal Medical Council (Bundesaerztekammer), which specifically exclude blood donations from subjects with severe health problems. For this study, only residual amounts of peripheral blood samples have been used.
Blood donors gave general written informed consent to the use of their blood samples in scientific studies, which would have been discarded otherwise. All samples were made anonymous before inclusion in this study. Furthermore, peripheral blood samples were collected for diagnostic purposes from patients with elevated liver values of unknown origin who presented at the University Medical Center Hamburg-Eppendorf (n = 100). All patients gave written consent that spare amounts of blood could be stored and tested in scientific studies.
Whole blood samples were centrifuged, and sera were stored deep-frozen until investigation for antibodies and viral RNA. Activities of liver-specific enzymes were measured in fresh bovine serum samples.
| Luciferase immunoprecipitation system (LIPS)
The predicted NS3 helicase encoding sequence of BovHepV/463/ Ger (GenBank accession KP641127) was amplified with primers bearing restriction sites (pREN2_NS3fragm_BamHI_fwd: 5′-GAG 
| RNA isolation, quantitative RT-PCR, reverse transcriptase PCR and phylogenetic analyses
Viral RNA was isolated from 140 μl of serum samples by using the Qiamp Viral RNA Mini Kit (Qiagen) and was eluted in 60 μl.
RNA from human samples was automatically extracted using the 
| Fluorescent in-situ hybridization (FISH)
FISH was performed on formalin-fixed, paraffin-embedded organ sections (liver, spleen, kidney, brain, lung, lung lymph nodes, and udder) of a BovHepV positive (BovHepV/463/Ger; KP641127 ) and negative cow using a BovHepV specific RNA probe targeting a fragment of the NS3 encoding sequence (KP641127; ViewRNA TYPE 1 Probe Sets; Thermo Fisher Scientific; ViewRNA ™ ISH Tissue Assay Kit (1-plex) and ViewRNA Chromogenic Signal Amplification Kit; Thermo Fisher Scientific) according to the manufacturer′s protocol as previously described (Pfaender et al., 2015; Postel, Hansmann, et al., 2016 
| Liver profile
Biochemical analysis included assessment of enzymatic activities of aspartate-aminotransferase (AST; GOT (ASAT)-Liquid UV IFCC, mti diagnostics GmbH), γ-glutamyl transferase (γ-GT; Gamma GT (GGT), standardized to IFCC, DIALAB GmbH), and glutamate dehydrogenase (GLDH; GLDH Cobas ® , Roche Diagnostics GmbH) and determination of total bilirubin (Bilirubin, Labor+Technik Lehmann GmbH). Measurements were carried out photometrically using an automated analysis system (ABX Pentra400, Horiba ABX Diagnostics).
| Statistical analysis
Results of AST, GGT, GLDH, and total bilirubin were tested for sta- 
| BovHepV specific antibodies and hepacivirus
RNA in other animal species and humans
To investigate the host specificity of BovHepV, the reactivity of serum samples from different animal species to BovHepV NS3 heli- 
| Course of infection in a BovHepV positive cattle herd
To investigate the progress of BovHepV infection under natural conditions over a longer time period we followed a virus positive dairy herd for 13 months. Initially, 40 dairy cows of a herd comprising 200 cows were sampled. Results of RT-PCR targeting presence of viral RNA in cattle's sera at this first herd visit have been described previously . During the following investigation period, several animals were removed from the herd. From the 40 cows which were initially sampled we here present results from 25 animals which stayed for at least ten more months in the herd. At each time point, several animals tested positive for BovHepV RNA by NS3-specific qRT-PCR. According to these results, animals were assigned to four cohorts for further analyses. Four animals (16%) gave positive qRT-PCR results for nine or more months, were classified as being persistently infected, and were placed in group 1 (animals #3, #6, #25, #35; Figure 3a ). Five animals (20%) were positive for viral RNA at several sampling occasions, and were assorted to the second group ("possible persistent BovHepV infection"; animals #9, #11, #12, #26, #40; Figure 3b ). Six cows (24%) tested positive at one to three sampling occasions (not more than 4 months) and were placed in group 3 ("acute BovHepV infections"; animals #17, #21, #31, #39, #24, #19; Figure 3c) . Remaining animals which never tested positive for viral RNA throughout the whole investigation period were classified as BovHepV negative and were placed in group 4 (data not shown). Overall, animals from group 1 displayed high amounts of viral RNA in their serum at each time point of investigation. Also, the highest concentration of viral RNA among all tested animals (more than 10 8 genome copies per ml serum) was found in this group (serum sample from animal #35 at the last time point of sampling). Animal #6 could not be tested at the second time point of sampling, whereas animal #25 could not be sampled at the last herd visit, but serum samples from these animals were confirmed to contain viral RNA at all remaining occasions (Figure 3a) . In sera of 
| Presence of BovHepV in the liver
In a previous study of the same herd investigated here, a high viral load of 2.92 × 10 5 genome equivalents per mg was found in liver material of a BovHepV positive cow, while other tissues (including spleen, kidney, brain, lung, lung lymph nodes, and udder) from the same animal contained <8.0 × 10 3 viral genome equivalents per mg . Here, we examined the same samples by The same analysis was performed for animals housed at the University's Clinic for Cattle. No significant differences considering mean values of hepatic enzymes and total bilirubin concentrations were observed between BovHepV positive and negative animals ( Figure 5c ).
| DISCUSSION
BovHepV was initially described in 2015. Apart from a preliminary estimate of virus prevalence, those first studies revealed that the virus shares key characteristics with HCV and the lately identified NPHV including the ability to initiate persistent infections in its host Corman et al., 2015) . To further enhance our current understanding of the biology of BovHepV infections we focused on additional aspects including course of infection, humoral immune response, host tropism, and zoonotic potential of BovHepV.
For serological screening of cattle and other potential hosts as well as for an enhanced description of infection progress in infected animals a species-independent LIPS was established; similar assays have been applied to detect NS3-antibody responses upon NPHV infections in earlier studies (Burbelo et al., 2012; Pfaender et al., 2015) .
With this, we investigated the frequency of BovHepV infections by screening a considerable number of bovine serum samples for antibodies and in addition for viral RNA. Serological analyses demonstrated that 30% of cattle herds had been exposed to the virus.
Real-time PCR completed the picture of BovHepV infections in domestic cattle in Germany; roughly 8% of serum samples were positive. A portion of these samples has been previously investigated by gel-based PCR resulting in a lower RNA detection rate . Enhanced BovHepV detection in the current study can most probably be attributed to newly designed primers binding to highly conserved regions of the 5′ UTR. It is worthy of note that another recent prevalence study from Germany revealed a BovHepV RNA detection rate of 14.8% (Schlottau et al., 2018) . Here, animals from 18 out of 150 herds tested BovHepV positive, while high intraherd percentages of viremic animals point at local BovHepV spread . Phylogenetic reconstruction demonstrated that BovHepV variants occupy a common branch in the tree of hepaciviruses. Interestingly, sequences from Germany fall into two distinct groups. Presence of two different clusters of BovHepV sequences from Germany has been illustrated recently (Schlottau et al., 2018) . Sequences representing both phylogenetic lineages described by Schlottau and co-workers correspond to the two different clusters described in our study. According to the phylogenetic tree, one of the sequence groups is more closely related to virus variants from Ghana than to remaining sequences from Germany.
While the close relationship of German and African BovHepV sequences can be explained by international trade or cattle movement between Europe and Africa, detailed information on cattle trade between Germany and Ghana was not available to us.
Extended sampling and analyses of bovine materials from Europe and other continents will be required to explore the global distribution and genetic diversity in more detail. horses (Pfaender et al., 2015 antibodies were both present for several months (Pfaender et al., 2015) . Apparently, those anti-NS3 serum antibodies had no neutralizing capacities in horses, but at least served as a marker for NPHV (Hoofnagle, 2002) . However, in individuals coinfected with HIV strong immunosuppression evoked through depletion of CD4+ T-cells can lead to lack of a detectable anti-HCV responses (George et al., 2002; Hadlich, Alvares-Da-Silva, Dal Molin, Zenker, & Goldani, 2007) . In cows, peripartum immunosuppression is a well-known phenomenon (Esposito, Irons, Webb, & Chapwanya, 2014) . Thus, it appears reasonable to assume that the sudden change of a gestational to a lactating state provoked by a poor metabolic condition and a negative energy balance can contribute to chronic manifestation of viral infections. Alternatively, it can be spec- lacking a serological response (Figure 3a) . Alternatively, the results obtained for animals of group 2 (like animals #9 and #12; Figure 3b) suggest that animals may acquire a possible persistent infection after birth without seroconversion. If BVDV-like mother-to-fetus infections or immune modulating effects are implicated in the epidemiology of BovHepV and establishment of persistent infection will be addressed in future studies.
Quantitative RT-PCR analyses of tissue samples from an infected animal showed the highest abundance of BovHepV RNA in the liver, suggesting that the bovine liver represents the primary site for BovHepV replication . In the current study, visualization of viral RNA in hepatocytes of the same animal by FISH techniques supports the assumption, that BovHepV is indeed a hepatotropic virus. In this context, we examined a possible role of BovHepV infection on hepatic impairment by measuring liver enzyme activities in bovine sera. However, BovHepV related liver damage mirrored by abnormal hepatic enzyme activity could not be observed during follow-up investigations of infected animals. Pfaender and coworkers followed serum activities of liver enzymes in two persistently NPHV infected horses and found that apart from one sharp peak of GLDH, serum activities of hepatic markers mainly stayed within reference ranges (Pfaender et al., 2015) . However, in acute NPHV infected horses, slight elevations of liver enzymes coincided with rise of serum antibodies (Pfaender et al., 2015 . In another study, symptoms of acute hepatitis reflected by rise of liver specific enzymes were seen after experimental infection of adult Arabian horses (Ramsay et al., 2015) . Here, comparison of liver parameters of BovHepV RNA or BovHepV antibody positive or negative cows showed that assessment of liver enzyme activities in serum samples is not supportive of diagnosing BovHepV infection.
Hepatic enzymes above threshold levels in BovHepV positive and negative animals might reflect symptoms accompanied with hepatic steatosis in high lactating dairy cows (Bogin, Avidar, Merom, Soback, & Brenner, 1988) . However, gestational or lactating status of the cows investigated here was not known to us. Taken together, the results of our study demonstrate that BovHepV shows properties of a liver-tropic virus and is highly prevalent in cattle herds in Germany.
With regard to a 13-month time frame investigated here, there is no evidence that BovHepV causes severe acute or chronic disease.
Future investigations addressing longer time periods and different age groups will clarify whether BovHepV is involved in liver injury in dairy cattle or other diseases of bovine species.
